Can I read mRNA-1273 Vaccine Phase 2 Trial Results on EtoBox?

mRNA-1273 Vaccine Phase 2 Trial Results by fakultaskedokteranumegabuana is a document available to read on EtoBox.

What is mRNA-1273 Vaccine Phase 2 Trial Results about?

Elsevier has established a COVID-19 resource center providing free information on the virus and has granted permission for unrestricted research use of its related content. A phase 2 trial of the mRNA-1273 vaccine demonstrated significant immune responses to SARS-CoV-2 in healthy adults aged 18 and older, with an acceptable safety profile. The study evaluated the safety and immunogenicity of two doses of the vaccine, showing higher antibody responses at the 100 mg dose compared to the 50 mg dose.

Author

fakultaskedokteranumegabuana

Language

EN